Related by context. All words. (Click for frequent words.) 71 Ischemic 71 Squamous Cell Carcinoma 70 Metastases 70 Thrombotic 70 Hematopoietic 70 Myocardial 70 Endothelial 69 Endometrial 69 Prolongs Survival 69 Left Ventricular 69 Skeletal Muscle 69 leiomyomas 69 Intracranial 68 Aortic Valve 68 Estrogen Receptor 68 Replacement Therapy 68 Pancreatic 68 Treating Chronic 68 Epithelial 68 Chronic Heart Failure 68 Renal Function 68 Exacerbation 68 Ischaemic 68 Transcriptional 68 Improves Outcomes 68 Attenuates 68 inducible nitric oxide synthase 67 Hypercholesterolemia 67 Androgen 67 Diabetic Nephropathy 67 Ranolazine 67 Carcinomas 67 Kidney Function 67 See CLINICAL PHARMACOLOGY 67 hepatocellular 67 Malignancies 67 Clinical Outcome 67 Fungal Infections 67 Progenitor Cells 67 Diabetic Neuropathy 67 metastatic malignant 67 Glucocorticoid 67 Dehydrogenase 67 Hemolysis 67 Septic Shock 67 Hematologic 67 tumor lysis syndrome 67 Macrophage 67 Esophageal 67 Lymphoid 67 hypereosinophilic syndrome 67 Decitabine 67 Mouse Model 67 endotoxemia 67 Cutaneous 67 Polymorphisms 67 Smooth Muscle 67 Hepatotoxicity 67 Overactive Bladder 67 Myocardial Ischemia 66 Prophylactic Treatment 66 Valvular 66 Unfractionated Heparin 66 Adjuvant Chemotherapy 66 Signaling Pathway 66 Chronic Renal Failure 66 Hematological 66 Placental 66 Secondary Hyperparathyroidism 66 chronic eosinophilic leukemia 66 murine model 66 Non Alcoholic Fatty 66 Peripheral Arterial 66 Antitumor 66 Allogeneic 66 Renal Artery 66 Renal Cell Carcinoma 66 Fibrinogen 66 NAGS deficiency 66 Patients Treated With 66 haematologic 66 Myelodysplastic Syndromes 66 Levels Linked 66 Patients Undergoing 66 Phosphorylation 66 occlusive disease 66 Oncogenic 66 Adenoviral 66 Uric Acid 66 Prostatic 66 Inhibits 66 Atypical Hemolytic Uremic Syndrome 66 Recombinant Human 66 Demonstrates Efficacy 66 Thiazolidinediones 66 Abdominal Fat 66 Immune Responses 66 Pharmacodynamics 66 Intracellular 66 Effectively Treats 66 Hepatocellular Carcinoma 66 Adenoma 66 Angiotensin II 66 Hypertrophic 66 Intracerebral 66 Resection 66 Intravascular 66 Fibrosis 66 Patency 66 Glucocorticoids 66 Oxidative 66 cystic fibrosis chronic pancreatitis 66 Liver Injury 66 Polymorphism 66 Shows Promise Against 66 Acute Ischemic Stroke 66 complement inhibitor eculizumab 66 cerebral vasospasm 66 Atherosclerotic 66 Oxidative Stress 66 Oral Fingolimod 66 Stenosis 65 Autoantibodies 65 Endothelial Function 65 Tumor Growth 65 granulomatous 65 Therapeutic Potential 65 Cyclooxygenase 2 65 urothelial 65 Ectopic 65 hypocalcaemia 65 Antitumor Activity 65 Uterine 65 Dendritic Cells 65 Drug Prevents 65 Epidermal Growth Factor Receptor 65 Gene Mutation 65 Hemorrhagic 65 Microalbuminuria 65 Neurotoxicity 65 hepatic cirrhosis 65 Hypertrophy 65 Catheter Associated 65 Nebulized 65 interstitial fibrosis 65 Thrombus 65 intracerebral 65 Leukemias 65 Angioedema 65 Relapsing Multiple Sclerosis 65 Hippocampal 65 Asymptomatic 65 Cardiotoxicity 65 Prognostic Factors 65 tumoral 65 Hypertensive Patients 65 Investigational Treatment 65 myelodysplastic myeloproliferative diseases 65 fibrin deposition 65 Fracture Risk 65 Neuronal 65 Pediatric Patients 65 Radiofrequency Ablation 65 Inhaled Corticosteroids 65 Improve Survival 65 Rheumatoid Arthritis Patients 65 Patients Receiving 65 esophageal carcinoma 65 Neoplasms 65 Diabetic Foot Ulcers 65 Immune Mediated 65 mesangial 65 Apoptotic 65 Progressive Multifocal Leukoencephalopathy 65 Immunosuppression 65 Phase 2a Clinical Trial 65 ST Segment Elevation 65 Known hypersensitivity 65 Controlled Trial 65 Occlusion 65 Papillary 65 Prospective Randomized 65 Lowers Risk 65 Clusterin 65 Meta Analysis 65 Non Alcoholic Steatohepatitis 65 treat benign prostatic 64 Carbamazepine 64 Atopic Dermatitis 64 thyrotropin 64 Malignant Melanoma 64 Benign Prostatic Hyperplasia 64 Liver Failure 64 Capsular 64 Advanced Renal Cell 64 Oral Formulation 64 Lambert Eaton Myasthenic 64 Extracellular Matrix 64 Intracerebral Hemorrhage 64 Soft Tissue Sarcoma 64 Acute Renal Failure 64 Allergic Rhinitis 64 bullous 64 Complicated Skin 64 adenomatous 64 aplasia 64 Antithrombin 64 Novel Mechanism 64 Inhibitory 64 Upregulation 64 Retinoic Acid 64 vascular endothelial 64 Subgroup Analysis 64 Reperfusion Injury 64 Polyneuropathy 64 Autologous Stem Cell Transplantation 64 rFVIIa 64 B Cell Lymphoma 64 Proliferative 64 hypothalamic pituitary adrenal axis 64 Radiofrequency Ablation RFA 64 Proteinuria 64 cytomegalovirus infection 64 Breast Cancer Recurrence 64 urothelial carcinoma 64 Drug Candidate 64 Adjuvant Treatment 64 Endocarditis 64 hyperphenylalaninemia HPA due 64 SIADH 64 Severe Sepsis 64 Chemokine Receptor 64 Orthostatic Hypotension 64 antiphospholipid syndrome 64 C1 Inhibitor 64 Fondaparinux 64 Inflammatory Markers 64 Immunologic 64 Aortic Stenosis 64 Transcription Factor 64 Increased Mortality 64 Sclerosing 64 Refractory Hodgkin Lymphoma 64 Elderly Patients 64 subependymal giant cell 64 Gastric Cancer 64 uricase 64 ACE Inhibitors 64 Modulates 64 Albuminuria 64 Dysplasia 64 underlying vasculopathy 64 extracellular signal 64 Chronic Sinusitis 64 Thrombocytopenia 64 Duodenal 64 AA Amyloidosis 64 downregulates 64 Embolic 64 Primary Hypercholesterolemia 64 paraneoplastic 64 Stent Restenosis 64 Portal Hypertension 64 Intracranial Aneurysms 64 Novel Oral 64 Sevelamer 64 Patients Treated 64 retinal ischemia 64 Pivotal Phase III 64 Nilotinib 64 Pioglitazone 64 urticaria hives 64 Thromboembolic 64 Tiotropium 64 Tumor Necrosis Factor 64 Gastrointestinal Tract 64 Interferon Alfa 64 Iron Overload 64 erythropoietic 64 Urethral 64 Surgical Treatment 64 Adenomas 64 Receptor Antagonists 64 nephrotoxicity 64 Diabetic Patients 64 Peptic Ulcer 64 acetonide FA 64 TNF Tumor Necrosis Factor 64 Secretion 64 J Am Coll 64 Oropharyngeal 64 Ventricular Tachycardia 64 Breast Cancer Metastasis 64 Appears Safe 64 Malignant Glioma 64 myeloperoxidase 64 Brain Metastases 64 Tumor Progression 64 Chemotherapy Induced 64 Immunomodulatory 64 vasodilatation 64 Cardiovascular Outcomes 64 Mitral Regurgitation 64 Metastatic Renal Cell Carcinoma 64 capillary leak 63 Aurora Kinase 63 adrenal insufficiency 63 left ventricular systolic 63 Heart Failure Patients 63 Cortical 63 Double Blind Randomized 63 Intestinal 63 Postprandial 63 familial amyloidotic polyneuropathy FAP 63 Long Term Efficacy 63 neutropenia thrombocytopenia 63 Aliskiren 63 Dysregulation 63 Antigen Specific 63 Microvascular 63 Predict Response 63 Pooled Analysis 63 symptomatic intracranial 63 carcinoid tumors 63 Induces 63 malignant ascites 63 Statistically Significant 63 PTHrP 63 Controlled Study 63 included exfoliative dermatitis 63 gastrointestinal GI perforation 63 Reduces Mortality 63 Renal Impairment 63 Novel Inhibitor 63 Proteasome 63 fallopian tube cancers 63 Left Ventricular Hypertrophy 63 Parathyroid 63 hypoperfusion 63 Neurogenesis 63 headache abdominal pain 63 Meets Primary Endpoint 63 Chronic Prostatitis 63 Pharmacologic 63 Endovascular Treatment 63 torsade de pointes 63 Clinical Efficacy 63 Randomized Controlled Trials 63 Embolization 63 Severe Asthma 63 Insulin Resistance 63 Oral Mucositis 63 Transgenic Mice 63 hip osteonecrosis avascular 63 muscarinic receptors 63 Hypotension 63 Study Evaluating 63 Enzyme Replacement Therapy 63 Factor Receptor 63 Biliary 63 IND Application 63 hyperammonemia 63 hepatic failure 63 Carotid 63 kidney urologic 63 Minimally Invasive Treatment 63 haemolysis 63 Stress Induced 63 Tacrolimus 63 Arrhythmogenic 63 atypical Hemolytic Uremic Syndrome 63 Hyperkalemia 63 targeted nucleotide prodrug 63 Randomized Study 63 Critically Ill Patients 63 Cognitive Deficits 63 Iron Deficiency 63 Eculizumab 63 Lymphocytic 63 Liprotamase 63 Tyrosine Kinase Inhibitor 63 Myoblast 63 von Willebrand Factor 63 Diabetic Foot Ulcer 63 exocrine 63 Hepatocellular 63 Hepatocytes 63 mediated inhibition 63 Myelodysplastic Syndrome 63 Intravitreal 63 interstitial pneumonia 63 Septal 63 Regenerative Cells 63 Immune Cell 63 Chronic Pelvic Pain 63 Fibroblast 63 Disease Progression 63 Keratitis 63 Ovarian Cancers 63 Fallopian Tube 63 pretransplant 63 Captopril 63 Cell Proliferation 63 Erythropoietic therapies may 63 renal tubular 63 myoclonus 63 Androgen Receptor 63 IL 1ß 63 Predict Risk 63 Tumor Response 63 Subclinical 63 coagulopathy 63 FDA Approvals 63 chronic thromboembolic pulmonary 63 Delayed Graft Function 63 gastric carcinoma 63 thrombocytosis 63 prostanoid 63 HepG2 cells 63 mucociliary clearance 63 QT Prolongation 63 Acute Decompensated Heart Failure 63 interleukin IL -# 63 Antiangiogenic 63 Eluting Stent 63 TNF Blockers 63 Peritoneal 63 Hemorrhagic Stroke 63 Prostaglandin 63 Solid Tumors 63 Epithelium 63 myelofibrosis polycythemia vera 63 Carotid Stenting 63 Blood Pressure Drug 63 Low Dose 63 Anticoagulants 63 Pivotal Trial 63 Phase 2b Clinical Trial 63 Toxicities 63 Transdermal Patch 63 Juvenile Idiopathic Arthritis 63 Endothelial Cells 63 fatty acid oxidation 63 alpha GAL 63 myomas 63 Mouse Models 63 pericardial effusion 63 Neuroprotection 63 vWF 63 Systemic Sclerosis 63 Small Intestine 63 LPS induced 63 Invasive Fungal Infections 63 Atresia 63 Azacitidine 63 fulminant hepatic failure 63 Mutational 63 renal fibrosis 63 Combo Therapy 63 Angina pectoris 63 Dual Antiplatelet Therapy 63 Postmenopausal Women 63 tryptase 63 Diffuse Large B 63 cardiac conduction 63 aminotransferase 63 Neoadjuvant Chemotherapy 63 Malignancy 63 Acute Lung 62 Cognitive Impairment 62 Neoplastic 62 Inflammatory Diseases 62 unstable angina pectoris 62 Hemangiomas 62 JAK2 enzyme 62 Slow Progression 62 Chronic Bronchitis 62 Hypothalamic 62 bronchogenic carcinoma 62 Hip Fractures 62 Therapeutic Efficacy 62 Tolerability 62 cholestasis 62 Oesophageal 62 colorectal carcinoma 62 Clinical Trial Results 62 experimental autoimmune encephalomyelitis 62 primary hyperparathyroidism 62 MR Angiography 62 Natalizumab 62 Infarction 62 Vertebral Fractures 62 Lipid Levels 62 Occlusive Disease 62 Tigecycline 62 selective modulator 62 Blood Flow 62 Adjunctive 62 Mitral valve 62 Antiplatelet 62 Comorbidities 62 autosomal dominant polycystic kidney 62 microglial activation 62 Ribavirin causes 62 Cytotoxicity 62 superficial femoral 62 Survival Benefit 62 humanized monoclonal 62 Thromboembolism 62 Chronic HCV 62 Subcutaneous 62 recurrent glioblastoma multiforme 62 Interferon Beta 62 hypothalamic pituitary 62 Lupus Nephritis 62 Autologous 62 Skin Lesions 62 Phase 2b Study 62 Calcification 62 Immunogenicity 62 CYT# potent vascular disrupting 62 liver metastasis 62 Inactivation 62 Ischemia 62 Proves Effective 62 dermatologic reactions 62 Suicidality 62 Nonalcoholic Fatty Liver Disease 62 Neurotransmitter 62 Therapeutic Effects 62 Coronary Artery Bypass Surgery 62 Radiation Induced 62 Adiposity 62 PAOD 62 Hyperlipidemia 62 Tumor Suppressor 62 Premature Infants 62 JAK Inhibitor 62 papillary renal cell carcinoma 62 Single Dose 62 Intra arterial 62 Orally Active 62 hepatic enzyme 62 ERK signaling 62 Neonatal Diabetes 62 Decompensated 62 hepatic dysfunction 62 Investigational Drug 62 Chronic Lymphocytic Leukemia 62 Sleep Disturbances 62 Coronary Artery 62 ANCA associated 62 Malformations 62 SHPT 62 Infected Patients 62 liver gallbladder 62 CLINICAL PHARMACOLOGY 62 Pulmonary Arterial Hypertension 62 Adjuvant Therapy 62 methicillin susceptible Staphylococcus aureus 62 alveolar epithelial cells 62 Cognitive Function 62 haematopoietic 62 degranulation 62 GRNCM1 62 Peginterferon Alfa 2a 62 vapreotide acetate 62 Mesenchymal Stem Cells 62 Treatment Resistant 62 NDA Submission 62 Endothelium 62 Vertebral Compression Fractures 62 bronchopulmonary 62 vascular permeability 62 Neurodegenerative 62 bFGF 62 Beta Blocker 62 mediastinitis 62 induce orthostatic hypotension 62 coronary vasodilation 62 Leber Hereditary Optic Neuropathy 62 Thyroid Hormone 62 Autoimmune Disease 62 bone marrow suppression 62 ileal 62 Fabry Disease 62 autophagic 62 Adenocarcinoma 62 Phase IIb Trial 62 metastatic neuroendocrine tumors 62 Coronary Angiography 62 hypervascular tumors 62 NAVISTAR R 62 SGPT 62 Mycophenolate Mofetil 62 J Am Soc 62 Cutaneous T 62 NSAID induced 62 Ultrasound Guided 62 Immunotherapeutic 62 Innate Immune 62 hepatic 62 Neuroprotective Effects 62 Cytochrome P# 62 Renal Cancer 62 Cell Transplants 62 Angiogenic 62 Enlarged Prostate 62 platelet activation 62 Homeostasis 62 Improves Survival 62 Subarachnoid hemorrhage 62 Endometrial Cancer 62 Dilatation 62 hepatorenal syndrome 62 chronic immune thrombocytopenic 62 Mg Usa 62 hyperprolactinemia 62 CEACAM1 62 Combination Treatment 62 cyclooxygenase 2 62 Treated Patients 62 Sjogren Syndrome 62 Cytotoxic 62 KL4 Surfactant 62 Histologic 62 R Saizen R 62 Acute Pancreatitis 62 Histological 62 Superoxide 62 Bacterial Vaginosis 62 Transdermal Delivery 62 Protease Inhibitors 62 neuritic 62 intrahepatic 62 Antibiotic Treatment 62 TNFalpha 62 Bucindolol 62 CTEPH 62 Paroxysmal 62 lymphangiogenesis 62 Pituitary 62 Monotherapy 62 Randomized Double blind 62 Well Tolerated 62 prostaglandin synthesis 62 Angiotensin Converting Enzyme 62 endothelial activation 62 Neuroendocrine Tumors 62 Venous Thromboembolism 62 hypogonadotropic hypogonadism 62 Itraconazole 62 HeFH 62 paragangliomas 62 thyrotoxicosis 62 hyperalgesia 62 Prematurity ROP 62 intravascular hemolysis 62 sclerosing 62 Basal Cell 62 Obese Patients 62 allogeneic hematopoietic stem cell 62 Lymph Node 62 hematological parameters 62 Hepatic Encephalopathy 62 Activator CK # 62 Clinical Relevance 62 Dilated Cardiomyopathy 62 Genes Linked 62 Mitomycin C 62 protein tyrosine phosphatase 1B 62 Cholesterol Lowering Drug 62 Subtypes 62 Phase III Clinical Trial 62 Stress Urinary Incontinence 62 Anti Tumor 62 neointimal hyperplasia 62 Statin Therapy 62 Guaifenesin 62 Unresectable 62 Tumor Suppressor Gene 62 Heterozygous Familial Hypercholesterolemia 62 gastrointestinal stromal tumors GISTs 62 Breast Density 62 neurological manifestations 62 Oxidase 62 Amniotic Fluid 62 Idiopathic 62 Monocytes 62 Tumor Targeting 62 polycythemia vera PV 62 artery stenosis 62 descending thoracic 62 Alkaline Phosphatase 62 Relapsing Remitting Multiple Sclerosis 62 artificial arteriovenous dialysis 62 Cell Lymphoma 62 cerebral ischemia 62 ara C 62 Hemodialysis Patients 62 Zorbtive TM 62 Patellofemoral 62 Cannabinoid 62 mitomycin C 62 Morquio 62 Knee Osteoarthritis 62 HIV HCV coinfected 62 Myeloid 62 Gene Linked 62 Placebo Controlled Study 62 intimal hyperplasia 62 sunitinib Sutent 62 progressive dyspnea 62 Node Positive 62 Artery Disease 62 Anthracycline 62 Precancerous 62 Myelofibrosis 62 Myoglobin 62 paroxysmal nocturnal hemoglobinuria 62 proximal tubule 62 Kidney Failure 62 Signaling Pathways 62 Epithelial Cells 62 Squalamine 62 Autoimmune Diseases 62 hypercalcaemia 62 hypercholesterolaemia 62 proteoglycan 62 Pharmacokinetics PK 62 Neuropathic 62 Bosentan 61 Bare Metal Stent 61 Phase Ib Clinical Trial 61 Rotavirus Vaccine 61 Pelvic Organ Prolapse 61 ERK1 2 61 ischemia reperfusion injury 61 Biolimus A9 61 natriuresis 61 Polymerase Inhibitor 61 saphenous vein graft 61 LHON 61 Vidaza azacitidine 61 Hormone Refractory Prostate Cancer 61 acute peripheral arterial 61 Squamous 61 Prognostic Value 61 Pharmacokinetic Study 61 Patient Outcomes 61 gastroduodenal 61 Acidosis 61 Drug Eluting 61 Percutaneous Transluminal Coronary Angioplasty 61 Immunosuppressant 61 Bronchiectasis 61 Synthetic Peptide 61 Antiviral Activity 61 monocytes macrophages 61 Cardiovascular Events 61 iobenguane 61 Vocal Cord 61 metabolic acidosis 61 Glycosylation 61 leiomyoma 61 Intravesical 61 endometrial hyperplasia 61 surgically resected 61 Pharmacological 61 cardiac contractility 61 Elevated serum 61 Urinary tract 61 nimodipine 61 Gastrointestinal Disorders 61 Prostacyclin 61 Cardiovascular Mortality 61 gene polymorphisms 61 hemorrhagic cystitis 61 Investigational Agent 61 Neutrophil 61 Placebo Controlled Trial 61 Histopathological 61 aneurysms AAA 61 extrahepatic 61 Am J Clin 61 Small Molecule 61 Respiratory Distress 61 Shows Promising 61 systemic hypotension 61 Sonographic 61 Parathyroid Hormone 61 Ventricular 61 JAK2 Inhibitor 61 Thrombin 61 Antisense Oligonucleotides 61 Glatiramer Acetate 61 Metastatic Colorectal Cancer 61 pulmonary metastases 61 Motility 61 Conjugated 61 Kinase Inhibitor 61 CYP#A# CYP#D# 61 Comorbid 61 ischemia driven 61 Gastrointestinal Stromal Tumors 61 Demonstrates Positive 61 Receives Orphan Drug Designation 61 J Am Acad 61 Rheumatoid 61 Safinamide 61 Atrial 61 Phase 2b Trial 61 Invasive Breast Cancer 61 mucinous 61 SSc 61 liver decompensation 61 Postoperative 61 Bosutinib 61 Renal Transplantation 61 Etiology 61 myeloproliferative diseases 61 Salivary 61 Novel Method 61 fosbretabulin 61 Successfully Treats 61 MGd 61 IMiDs ® compound 61 Overexpression 61 transthyretin TTR mediated amyloidosis 61 vasoactive 61 Antidepressants Linked 61 Contralateral 61 cardiogenic 61 secondary hyperparathyroidism 61 Coronary Arteries 61 Tumor Cell 61 unknown etiology 61 Diastolic Heart Failure 61 myocardial infarction ventricular fibrillation 61 Preclinical Study 61 STRIDE PD 61 Dupuytren Contracture 61 Angiographic 61 Breast Cancer Cells 61 Breast Tissue 61 dual endothelin receptor antagonist 61 VEGF expression 61 Minimally Invasive Procedure 61 Genetic Mutation 61 Potent Inhibitor 61 IL 1beta 61 Fenofibrate 61 Ureteral 61 Randomized Clinical Trial 61 Cerebellar 61 G CSFs 61 Insulin Sensitivity 61 Coronary Artery Bypass Graft 61 Cardiovascular Disease Risk 61 Thymic 61 platelet dysfunction 61 tonsillar 61 Venous Thrombosis 61 Catheter Ablation 61 Preclinical Efficacy 61 ACER paper 61 Renal Anemia 61 Pericardial 61 Chemotherapy induced 61 Bone Metastases 61 Effective Treatments 61 Antibiotic Resistant 61 sinus tachycardia 61 malignant neoplasms 61 moderate hepatic impairment 61 Ovarian Cancer Risk 61 experimentally induced 61 Epithelial Cell 61 ABCB1 61 serum phosphate 61 colorectal adenoma 61 Reduced Risk 61 hyperparathyroidism 61 suppurative 61 HIF 1a 61 metaplasia 61 Anti Tumor Activity 61 Epstein Barr Virus EBV 61 Genetic Variation 61 Bronchopulmonary Dysplasia 61 ischemia induced 61 Aneurysm Repair 61 Posaconazole 61 Antifungal 61 Hyperphosphatemia 61 Irritable Bowel 61 Transthyretin 61 syngeneic 61 Heart Transplant Recipients 61 diabetic gastroparesis 61 Phase IIa Clinical Trial 61 Murine Model 61 Refractory Angina 61 Is Well Tolerated 61 Pafuramidine 61 Glomerular 61 Epidermal 61 Circadian Clock 61 Serostim R 61 Polycythemia Vera 61 Hyperuricemia 61 Epratuzumab 61 Bronchial 61 Fas ligand 61 duodenal 61 arteriovenous malformations 61 Multiple Myeloma Patients 61 Novel Small Molecule 61 proteolysis 61 Atrophic 61 glomerular 61 Lysis 61 A1PI 61 Mimetics 61 eosinophilia 61 Drug Resistant 61 Laryngeal Cancer 61 Preclinical Evaluation 61 Ascites 61 Zollinger Ellison Syndrome 61 Bacterial Infections 61 acute hepatic 61 Lenalidomide 61 Hyperparathyroidism 61 RNAi Therapeutic 61 Hematopoietic Stem Cells 61 Dose Response 61 Adverse Effects 61 Lung Tumors 61 hepatic glucose production 61 Factor XIII 61 pulmonary alveolar 61 pancytopenia 61 Contraindications 61 Gene Variants 61 Cytarabine 61 Receptor Agonist 61 Dyslipidemia 61 allergen induced 61 Candesartan 61 Escherichia coli Klebsiella pneumoniae 61 Incretin 61 Nocturia 61 Post Operative 61 AST ALT 61 hyperplasia 61 Cardiac Function 61 Pathogenesis 61 Uterine Cancer 61 Etanercept 61 Castration Resistant Prostate Cancer 61 Axillary 61 Neovascular Age Related Macular 61 Sexual Desire 61 Targeted Therapy 61 Vascular Inflammation 61 Lung Injury 61 Symptom Relief 61 E selectin 61 Oral Insulin 61 Kidney Transplant Patients 61 metastatic gastric 61 Muscarinic 61 Transcatheter 61 Mucositis 61 vascular reactivity 61 Pramlintide 61 splanchnic 61 Antiplatelet Therapy 61 arterial hypertension 61 Arrhythmias 61 Postherpetic Neuralgia 61 Oral Cavity 61 Candidiasis 61 Slows Progression 61 PKC# 61 Pharmacodynamic 61 Drug Combo 61 mesenteric 61 Idiopathic Pulmonary Fibrosis 61 novel VDA molecule 61 hemolytic 61 hyperresponsiveness 61 leukocyte infiltration 61 Endoplasmic Reticulum 61 Preterm Delivery 61 Friedreich Ataxia FRDA 61 lactate dehydrogenase LDH 61 Paraplatin ®